Dow Up 0.04% Nasdaq Up 0.89%

Novo Nordisk A/S (NVO)

-NYSE
44.46 Up 0.17(0.38%) 4:03PM EST
|After Hours : 44.46 0.00 (0.00%) 5:17PM EST
Prev Close:44.29
Open:44.53
Bid:43.65 x 1000
Ask:46.00 x 100
1y Target Est:49.37
Beta:0.89
Next Earnings Date:N/A
Day's Range:44.32 - 44.64
52wk Range:34.30 - 49.11
Volume:1,001,863
Avg Vol (3m):1,452,000
Market Cap:116.21B
P/E (ttm):26.85
EPS (ttm):1.66
Div & Yield:0.61 (1.40%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
NVOUp 0.38%116.21B
LLYDown 0.64%71.59B
PFEDown 0.76%190.41B
SNYUp 0.34%124.15B

Key Statistics

Forward P/E (1 yr):22.45
P/S (ttm):8.00
Ex-Dividend Date:21-Mar-14

Analysts

Annual EPS Est (Dec-14) :1.73
Quarterly EPS Est (Jun-14) :N/A
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):2.03

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novo Nordisk A/S engages in the discovery, development, manufacture, and marketing of pharmaceutical products primarily in Denmark. It operates in two segments, Diabetes Care and Biopharmaceuticals. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback